Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 33/75 ]
NASDAQ | Common Stock
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally.
Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax.
The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer.
NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 26, 26 | -0.22 Increased by +63.93% | -0.41 Increased by +46.01% |
| Oct 30, 25 | -0.33 Decreased by -17.86% | -0.42 Increased by +21.43% |
| Jul 24, 25 | -0.36 Decreased by -16.13% | -0.38 Increased by +5.26% |
| Jun 5, 25 | -0.31 Increased by +13.89% | -0.46 Increased by +33.19% |
| Feb 27, 25 | -0.61 Decreased by -35.56% | -0.36 Decreased by -69.44% |
| Oct 30, 24 | -0.28 Increased by +39.13% | -0.33 Increased by +15.15% |
| Jul 25, 24 | -0.31 Increased by +42.59% | -0.41 Increased by +24.39% |
| May 2, 24 | -0.36 Increased by +28.00% | -0.42 Increased by +14.29% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 174.35 M Increased by +8.11% | -24.50 M Increased by +62.84% | Decreased by -14.05% Increased by +65.63% |
| Sep 30, 25 | 167.20 M Increased by +7.81% | -37.27 M Decreased by -21.92% | Decreased by -22.29% Decreased by -13.09% |
| Jun 30, 25 | 158.81 M Increased by +5.62% | -40.14 M Decreased by -20.27% | Decreased by -25.28% Decreased by -13.87% |
| Mar 31, 25 | 154.99 M Increased by +11.91% | -34.32 M Increased by +11.46% | Decreased by -22.14% Increased by +20.88% |
| Dec 31, 24 | 161.27 M Increased by +20.54% | -65.92 M Decreased by -40.02% | Decreased by -40.88% Decreased by -16.16% |
| Sep 30, 24 | 155.09 M Increased by +21.81% | -30.57 M Increased by +38.22% | Decreased by -19.71% Increased by +49.29% |
| Jun 30, 24 | 150.36 M Increased by +19.28% | -33.38 M Increased by +41.87% | Decreased by -22.20% Increased by +51.27% |
| Mar 31, 24 | 138.50 M Increased by +13.36% | -38.76 M Increased by +26.95% | Decreased by -27.98% Increased by +35.56% |